NeurAxis (NASDAQ:NRXS) Trading Down 0.9% – Here’s What Happened

NeurAxis, Inc. (NASDAQ:NRXS)’s share price fell 0.9% during trading on Tuesday . The company traded as low as $2.15 and last traded at $2.15. 1,796 shares changed hands during trading, a decline of 88% from the average session volume of 14,753 shares. The stock had previously closed at $2.17.

NeurAxis Stock Down 2.3 %

The firm has a market cap of $15.07 million, a P/E ratio of -1.14 and a beta of 4.20. The business has a fifty day moving average of $2.42 and a 200 day moving average of $2.67.

Hedge Funds Weigh In On NeurAxis

An institutional investor recently raised its position in NeurAxis stock. Parsons Capital Management Inc. RI lifted its holdings in NeurAxis, Inc. (NASDAQ:NRXS) by 797.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 116,726 shares of the company’s stock after purchasing an additional 103,726 shares during the quarter. Parsons Capital Management Inc. RI owned about 1.67% of NeurAxis worth $274,000 as of its most recent SEC filing. 11.77% of the stock is currently owned by hedge funds and other institutional investors.

NeurAxis Company Profile

NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.